Success Stories: A Scientist Working in the Field of Pharmaceutical Sciences Achieves EB1B Case Approval with the Help of Our Assistance

Client’s Testimonial:

“Thank you very much for your help with this. It was not possible without your firm.”

On March 15^th, 2023, we received another EB-1B (Outstanding Professors and Researchers) approval for a Scientist in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Scientist

Country of Origin: India

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: March 15^th, 2023

Processing Time: 1 month, 19 days

Case Summary:

A Scientist contacted our law firm to help her establish her significant contributions to the U.S. by filing for an EB-1B (Outstanding Professors and Researchers) visa category. We presented her unique executive background and unprecedented experience necessary to her current and future work at the USCIS.

Upon reviewing her credentials, we found that our client has completed her:

Ph.D. in Pharmaceutical Sciences in Medicinal Chemistry and has an unparalleled documented record of authorship in her field of endeavor.
Her work has been published in some of the most prestigious, high-impact journals resulting in 13 peer-reviewed scientific articles.
Moreover, she has already conducted at least 23 reviews for journals to date and her work has been cited by other scholars in numerous published articles as well. According to Google Scholar, her work has been cited a total of 224 times.

Furthermore, our client’s research addresses some of our nation’s most pressing issues in understanding the use of small molecules for improving the efficacy of cancer drugs. Her strong background in pharmacy and medicinal chemistry has allowed her research to be particularly original, with applications such as drug delivery, and cancer prevention and treatment. She is particularly well-known for her work on the structural modification of the aryl sulfonate ester of Cjoc42 for enhanced gankyrin binding and anti-cancer activity.

Her case was supported by four recommendation letters that she obtained from her fellow experts in the field, corroborating how her work has helped set the course for much subsequent research in this area. Therefore, one of the recommenders stated:

“Without question, [client] credentials and research expertise fully merit the continued opportunity to pursue further pharmaceutical research in the United States. The success, influence, and overall excellence of [client’s] work to date make it clear that she is a rising star in her field with the potential of advancing the field of pharmaceutical sciences for years to come.”

The totality of this evidence, thus shows that our client has been internationally recognized and fully qualified as an outstanding researcher in her field of expertise. Her impressive background, strong record of past achievements, recognition of expertise by journals seeking her services to review manuscripts, and unique knowledge relevant to her ongoing work all indicate that she not only qualifies as an outstanding researcher, but also that she is recognized internationally for her accomplishments within the field.

We would like to congratulate her on securing her EB1B case approval, which was adjudicated in only 2 months days instead of 9-12 months. We wish her to receive her green card as soon as possible.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.